Lawyers for the Lifecycle of Foods, Dietary Supplements,
Cosmetics, Drugs & Medical Devices

Rend Al-Mondhiry Elevated To Partner At Amin Talati

Amin Talati Wasserman LLP announced today that Rend Al-Mondhiry has been elevated to Partner of the firm. Rend is one of the most well-known and respected attorneys serving the dietary supplement industry.  Since joining the MORE >

see all news >

Food & Beverage

We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness: food and beverages, nutritional supplements, and cosmetics.

MORE

Intellectual Property

Drawing heavily on our IP, patent and trademark expertise, we provide our clients with business advice and strategies that enhance product value and head off future litigation.

MORE

Litigation

We are deeply experienced in FDA and FTC disputes, patent and trademark infringement cases, class actions, breach of contract and unfair competition claims. We are renowned in the area of Paragraph IV litigation, where companies challenge brand name patents so that medications can be marketed in generic forms.

MORE

Drugs & Devices

We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.

MORE
What's New
  • news

    Importing hemp into U.S. remains ‘total crapshoot’

    Although the 2018 Farm Bill removed hemp and its derivatives with a THC concentration of no more than 0.3% from the Controlled Substances Act (CSA), government agencies reportedly face technological challenges testing for the THC threshold at the U.S. borders. Josh Long | Dec 16, 2019 Despite the publication of interim regulations from USDA regarding domestic production […]

  • news

    IS YOUR PRODUCT REGULATED BY FDA? IF IT’S ELECTRONIC, IT MAY BE

    By Neil F. O’Flaherty     Partner      Amin Talati Wasserman LLP Introduction Almost everyone knows that the U.S. Food and Drug Administration (FDA) regulates food, drugs, cosmetics, medical devices and even tobacco products.  We see references to FDA and these types of products all the time in TV news reports, articles, and even on […]

  • news

    Ivan Wasserman to Speak on Commercial and Legal Implications Taxonomic Changes to the Genus Lactobacillus

    Join Ivan Wasserman as he discusses commercial and legal implications taxonomic changes to the genus lactobacillus. The webinar will take place December 11 at 12:30pm Eastern/9:30am Pacific. For more information click here.